Related Experiment Videos
Amiodarone-induced dysthyroidism
Abstract:
A 54-year-old man, treated with amiodarone, developed thyrotoxicosis. When rechallenged with the same drug 6 months later, he developed hypothyroidism. The therapeutic implications of this clinical sequence are discussed.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo-controlled superiority study (VANISH 306).
BJOG : an international journal of obstetrics and gynaecology·2021
Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species.
Expert opinion on pharmacotherapy·2018
Characteristics of low-risk patients hospitalized with community-acquired pneumonia.
European journal of internal medicine·2007
Electroencephalography in the evaluation of headache patients: a review.
Israel journal of medical sciences·1998
Complementary medicine--a critical review.
Israel journal of medical sciences·1998
The Israel Longitudinal Mortality Study--differential mortality in Israel 1983-1992: objectives, materials, methods and preliminary results.
Israel journal of medical sciences·1998
Detection and typing of human papillomavirus DNAs by restriction endonuclease mapping of the PCR products.
Israel journal of medical sciences·1998
A comparison between arterial- and venous-sampled activated clotting time measurements.
Israel journal of medical sciences·1998
Heart rate variability in patients with secondary amyloidosis.
Israel journal of medical sciences·1998
Paracetamol overdose: systematic review of case reports and national toxicological data (2018-2023).
Central European journal of public health·2026
Trends in Dispensing of Opioids and Benzodiazepines Among Older Adults Admitted for an Acute Hip Fracture Between 2008 and 2024 in Ontario, Canada.
Journal of the American Geriatrics Society·2026
Comparative effectiveness and safety of topiramate versus amitriptyline for the prophylactic management of chronic migraine: a prospective comparative study.
Frontiers in pain research (Lausanne, Switzerland)·2026